JP2020531511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531511A5 JP2020531511A5 JP2020511176A JP2020511176A JP2020531511A5 JP 2020531511 A5 JP2020531511 A5 JP 2020531511A5 JP 2020511176 A JP2020511176 A JP 2020511176A JP 2020511176 A JP2020511176 A JP 2020511176A JP 2020531511 A5 JP2020531511 A5 JP 2020531511A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- patient
- eye
- micrograms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 25
- 239000003889 eye drop Substances 0.000 claims 14
- 229940126062 Compound A Drugs 0.000 claims 8
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 8
- 229940012356 eye drops Drugs 0.000 claims 8
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 6
- 230000004489 tear production Effects 0.000 claims 6
- 239000013543 active substance Substances 0.000 claims 4
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762549872P | 2017-08-24 | 2017-08-24 | |
| US62/549,872 | 2017-08-24 | ||
| PCT/US2018/048025 WO2019040919A1 (en) | 2017-08-24 | 2018-08-24 | OCULAR PHARMACEUTICAL COMPOSITIONS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020531511A JP2020531511A (ja) | 2020-11-05 |
| JP2020531511A5 true JP2020531511A5 (https=) | 2021-09-30 |
Family
ID=65439930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511176A Pending JP2020531511A (ja) | 2017-08-24 | 2018-08-24 | 眼球用医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11839616B2 (https=) |
| EP (1) | EP3672598A4 (https=) |
| JP (1) | JP2020531511A (https=) |
| KR (1) | KR20200044873A (https=) |
| CN (1) | CN111629730A (https=) |
| AU (1) | AU2018321926B2 (https=) |
| CA (1) | CA3073718A1 (https=) |
| WO (1) | WO2019040919A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016379444B2 (en) | 2015-12-24 | 2021-04-29 | The Regents Of The University Of California | CFTR regulators and methods of use thereof |
| JP2020531511A (ja) | 2017-08-24 | 2020-11-05 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | 眼球用医薬組成物 |
| US11957413B2 (en) * | 2019-08-06 | 2024-04-16 | University of Pittsburgh—of the Commonwealth System of Higher Education | Solitary wave-based trans-lid tonometer |
| CN115397392A (zh) * | 2019-12-05 | 2022-11-25 | Vanda制药公司 | 眼用药物组合物 |
| JP7826294B2 (ja) * | 2020-09-10 | 2026-03-09 | バンダ・ファーマシューティカルズ・インコーポレイテッド | Pdeiv媒介性の疾患又は状態を処置する方法 |
| WO2025179141A1 (en) * | 2024-02-22 | 2025-08-28 | Vanda Pharmaceuticals, Inc. | Treatment of dry eye disease |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0008864A1 (en) | 1978-08-15 | 1980-03-19 | FISONS plc | Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| JPS62126178A (ja) | 1985-11-26 | 1987-06-08 | Mitsubishi Petrochem Co Ltd | 新規トリアジン誘導体及びこれを含む除草剤 |
| US5236952A (en) | 1986-03-11 | 1993-08-17 | Hoffmann-La Roche Inc. | Catechol derivatives |
| AU5433594A (en) | 1992-11-19 | 1994-06-08 | Dainippon Pharmaceutical Co. Ltd. | 3,4-dihydro-1-(2-hydroxyphenyl)-2(1h)-quinoxalinone derivative and related compound |
| WO1999038497A2 (en) | 1998-01-30 | 1999-08-05 | R-Tech Ueno, Ltd. | Ophthalmic composition |
| EP0945447A1 (en) | 1998-03-27 | 1999-09-29 | Janssen Pharmaceutica N.V. | Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections |
| CA2319554C (en) | 1998-03-31 | 2005-06-28 | Warner-Lambert Company | Quinoxalinones as serine protease inhibitors such as factor xa and thrombin |
| CA2394727A1 (en) | 1999-12-28 | 2001-07-05 | Pharmacopeia, Inc. | Pyrimidine and triazine kinase inhibitors |
| US7163943B2 (en) | 2001-09-21 | 2007-01-16 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| RS34004A (sr) | 2001-09-21 | 2006-10-27 | Reddy Us Therapeutics Inc. | Postupci i sastavi novih triazin jedinjenja |
| AU2003272740A1 (en) | 2002-10-01 | 2004-04-23 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 4,6-diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors |
| AU2004259346A1 (en) | 2003-07-22 | 2005-02-03 | Neurogen Corporation | Substituted pyridin-2-ylamine analogues |
| BRPI0507278A (pt) | 2004-01-30 | 2007-06-26 | Vertex Pharma | moduladores dos transportadores do cassete de ligação ao atp |
| US7335770B2 (en) | 2004-03-24 | 2008-02-26 | Reddy U5 Therapeutics, Inc. | Triazine compounds and their analogs, compositions, and methods |
| DE102004023332A1 (de) | 2004-05-12 | 2006-01-19 | Bayer Cropscience Gmbh | Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung |
| WO2007095812A1 (en) | 2006-02-27 | 2007-08-30 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Substituted [1,3,5] triazine compounds, their processes for preparation and uses thereof |
| EP2037924A2 (en) | 2006-07-07 | 2009-03-25 | Steven P. Govek | Bicyclic heteroaryl inhibitors of pde4 |
| US8263607B2 (en) | 2007-05-22 | 2012-09-11 | Astellas Pharma Inc. | 1-substituted tetrahydroisoquinoline compound |
| US20090105240A1 (en) | 2007-10-17 | 2009-04-23 | Tomas Mustelin | Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same |
| US20120009151A1 (en) | 2007-12-21 | 2012-01-12 | Progenics Pharmaceuticals, Inc. | Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
| HUE027811T2 (en) | 2008-03-05 | 2016-11-28 | Merck Patent Gmbh | Quinoxalinone derivatives as stimulators of insulin secretion, methods for their preparation and their use in the treatment of diabetes |
| WO2010048564A1 (en) | 2008-10-23 | 2010-04-29 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
| WO2010073011A2 (en) | 2008-12-23 | 2010-07-01 | Betagenon Ab | Compounds useful as medicaments |
| PL2408750T3 (pl) | 2009-03-20 | 2016-02-29 | Vertex Pharma | Sposób otrzymywania modulatorów błonowego regulatora przewodnictwa swoistego dla mukowiscydozy |
| FR2958645B1 (fr) | 2010-04-09 | 2012-08-31 | Commissariat Energie Atomique | Hemi-anticorps a auto-assemblage |
| MX353408B (es) | 2010-04-22 | 2018-01-11 | Vertex Pharma | Proceso para producir compuestos de cicloalquilcarboxamido-indol. |
| US8883793B2 (en) | 2010-12-29 | 2014-11-11 | Development Center For Biotechnology | Tubulin inhibitors and methods of using the same |
| AU2013365827A1 (en) | 2012-12-19 | 2015-07-09 | Novartis Ag | Tricyclic compounds as CFTR inhibitors |
| PT3030568T (pt) | 2013-08-08 | 2018-12-24 | Galapagos Nv | Tieno[2,3-c]piranos como moduladores de cftr |
| WO2015168079A1 (en) | 2014-04-29 | 2015-11-05 | Infinity Pharmaceuticals, Inc. | Pyrimidine or pyridine derivatives useful as pi3k inhibitors |
| EP3347912A1 (de) | 2015-09-11 | 2018-07-18 | ION-TOF Technologies GmbH | Sekundärionen-massenspektrometer und sekundärionen-massenspektrometrisches verfahren |
| US10035962B2 (en) * | 2015-12-21 | 2018-07-31 | Exxonmobil Research And Engineering Company | Trim dewaxing of distillate fuel |
| BR112018012934B1 (pt) | 2015-12-24 | 2023-11-07 | The Regents Of The University Of California | Reguladores cftr e métodos de uso dos mesmos |
| RU2742934C2 (ru) | 2015-12-24 | 2021-02-11 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорниа | Кфтр регуляторы и способы их применения |
| AU2016379444B2 (en) | 2015-12-24 | 2021-04-29 | The Regents Of The University Of California | CFTR regulators and methods of use thereof |
| PL3722291T3 (pl) | 2015-12-24 | 2023-11-27 | Respivert Limited | Związki indolinonowe i ich zastosowanie w leczeniu chorób zwłóknieniowych |
| JP2020531511A (ja) | 2017-08-24 | 2020-11-05 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | 眼球用医薬組成物 |
-
2018
- 2018-08-24 JP JP2020511176A patent/JP2020531511A/ja active Pending
- 2018-08-24 US US16/641,621 patent/US11839616B2/en active Active
- 2018-08-24 CN CN201880069116.7A patent/CN111629730A/zh active Pending
- 2018-08-24 WO PCT/US2018/048025 patent/WO2019040919A1/en not_active Ceased
- 2018-08-24 CA CA3073718A patent/CA3073718A1/en active Pending
- 2018-08-24 AU AU2018321926A patent/AU2018321926B2/en active Active
- 2018-08-24 EP EP18849250.8A patent/EP3672598A4/en active Pending
- 2018-08-24 KR KR1020207008360A patent/KR20200044873A/ko not_active Ceased
-
2023
- 2023-10-30 US US18/497,962 patent/US20240156828A1/en not_active Abandoned
-
2025
- 2025-08-11 US US19/296,874 patent/US20250367207A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020531511A5 (https=) | ||
| Moiseev et al. | Penetration enhancers in ocular drug delivery | |
| JP7012075B2 (ja) | 眼瞼炎の治療に使用するための医薬組成物 | |
| JP7082115B2 (ja) | 異常な新生血管形成を伴う眼疾患を処置するためにニンテダニブを使用する組成物および方法 | |
| CN105307498B (zh) | 用于治疗眼病的组合物、制剂和方法 | |
| WO2017158366A3 (en) | Ophthalmic delivery device and ophthalmic drug compositions | |
| NZ785712A (en) | Neuroactive steroids, compositions, and uses thereof | |
| RU2017129247A (ru) | Способы и композиции для лечения болезни сухого глаза и других глазных заболеваний | |
| JP2018506570A5 (https=) | ||
| JP2009530234A5 (https=) | ||
| JP2011516477A5 (https=) | ||
| Gallagher et al. | Development of a poly-ε-lysine contact lens as a drug delivery device for the treatment of fungal keratitis | |
| JP2017520527A5 (https=) | ||
| TN2010000251A1 (fr) | N-acetyl-dl-leucine medicament neuro et retino protecteur | |
| JP2013534527A5 (https=) | ||
| EA201300314A8 (ru) | Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство | |
| Cegielska et al. | Targeted drug delivery systems for the treatment of glaucoma: Most advanced systems review | |
| WO2016208961A1 (ko) | 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물 | |
| JP6871400B2 (ja) | 眼表面疾患の治療のための製剤および関連方法 | |
| US9320645B2 (en) | Approach to administering ocular medication | |
| JP2018500546A5 (https=) | ||
| JP2008540528A5 (https=) | ||
| EP4225279A1 (en) | Drug containing dissolvable ocular inserts and method of using same | |
| JP2018519299A (ja) | 組成物および治療方法 | |
| JP2019502719A5 (https=) |